The following table provides an overview of the latest patents of Ludwig Institute For Cancer Research that has been opposed by its competitors. It provides an insight into the competitive landscape of the industry and highlights the patents that are subject to oppositions.

Patent NumberGrant DateTitleTotal Oppositions
EP3022320Sep 25, 2024Whole-Genome And Targeted Haplotype Reconstruction3
EP2906696Dec 14, 2022Methods For Modulating C9Orf72 Expression4